Outlook Therapeutics Inc. (NASDAQ: OTLK)
$5.0900
-0.0400 ( -0.97% ) 132.7K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$5.0900
Previous close
$5.1300
Volume
132.7K
Market cap
$120.41M
Day range
$4.9860 - $5.2550
52 week range
$4.6100 - $12.8499
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 16 | Feb 14, 2024 |
| 10-q | Quarterly Reports | 70 | Feb 14, 2024 |
| ars | Annual reports | 1 | Feb 08, 2024 |
| def | Proxies and info statements | 6 | Feb 08, 2024 |
| pre | Proxies and info statements | 6 | Jan 29, 2024 |
| 8-k | 8K-related | 22 | Jan 24, 2024 |
| 10-k/a | Quarterly Reports | 14 | Jan 24, 2024 |
| 10-k | Annual reports | 85 | Dec 22, 2023 |
| 8-k | 8K-related | 13 | Dec 22, 2023 |
| 8-k | 8K-related | 12 | Dec 06, 2023 |